DS
CCXI

DRW Securities’s ChemoCentryx, Inc. CCXI Stock Holding History

DRW Securities’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-23,000
Closed -$133K – 259
2013
Q4 		$133K Buy
23,000
+4,995
+28% +$25.8K 0.01% 203
2013
Q3 		$92K Buy
+18,005
New +$195K 0.01% 156

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DRW Securities's CCXI Position: Q1 2014 in Review

DRW Securities sold out of ChemoCentryx, Inc. (CCXI) in Q1 2014, closing a stake of 23,000 shares — an estimated $133K sold.

DRW Securities first reported a position in CCXI in Q3 2013 and held it in 2 quarters. The position peaked at $133K in Q4 2013. 65 funds tracked by Wall St. Rank hold CCXI as of Q1 2014.

  • DRW Securities reported no remaining ChemoCentryx, Inc. position as of Q1 2014 after selling out during the quarter.
  • DRW Securities sold 23,000 ChemoCentryx, Inc. shares in Q1 2014, an estimated $133K.
  • DRW Securities first reported a position in ChemoCentryx, Inc. in Q3 2013 and held it in 2 quarters.
  • DRW Securities's ChemoCentryx, Inc. position peaked at $133K in Q4 2013.
  • 65 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2014.

Based on DRW Securities's 13F filing for Q1 2014, filed 16 May 2014.